Atrioventricular nodal reentrant tachycardia (AVNRT) is a type of arrhythmia that affects the heart’s electrical system and causes an abnormally rapid heartbeat. It is one of the most common forms of tachycardia, or rapid heart rate, and is usually seen in younger people. AVNRT is usually benign and does not cause any long-term damage to the heart. However, it can cause symptoms such as dizziness, lightheadedness, palpitations, chest pain, and shortness of breath, which can be quite uncomfortable. The electrical system of the heart is composed of four chambers, the atria and the ventricles. Electrical signals travel through the atria and then the ventricles, causing them to contract in a coordinated manner. In AVNRT, a reentrant circuit is created within the atrioventricular node (AV node), which is a small area of specialized tissue located between the atria and the ventricles. This circuit causes the electrical signals to be delayed, resulting in a rapid heartbeat.
The AV node is a small area of specialized tissue located between the atria and the ventricles. It is composed of two main components: the sinus node and the atrioventricular node. The sinus node is responsible for generating the electrical signals that cause the heart to beat. The AV node is responsible for conducting the electrical signals from the atria to the ventricles. The AV node is composed of several different types of cells, including Purkinje cells, myocytes, and fibroblasts. The Purkinje cells are responsible for conducting the electrical signals from the sinus node to the atria and the ventricles. The myocytes are responsible for conducting the electrical signals from the atria to the ventricles. Finally, the fibroblasts are responsible for providing structural support to the AV node.
AVNRT is caused by a reentrant circuit within the AV node. This circuit is created when the electrical signals travel from the sinus node to the atria, and then back to the sinus node. This creates a loop, which causes the electrical signals to be delayed, resulting in a rapid heartbeat. The reentrant circuit is created when the electrical signals travel down two different pathways within the AV node. The first pathway is the slow pathway, which is composed of Purkinje cells. The second pathway is the fast pathway, which is composed of myocytes. The slow pathway conducts the electrical signals from the sinus node to the atria, and then back to the sinus node. The fast pathway conducts the electrical signals from the atria to the ventricles, and then back to the atria. When the electrical signals travel down both pathways, they create a loop, which causes the electrical signals to be delayed, resulting in a rapid heartbeat.
AVNRT is usually diagnosed through an electrocardiogram (ECG) or an echocardiogram. An ECG is used to measure the electrical activity of the heart, and can help to identify if there is a reentrant circuit within the AV node. An echocardiogram is used to measure the structure and function of the heart, and can help to identify any underlying causes of the arrhythmia. AVNRT can usually be treated with medication or with a procedure known as radiofrequency ablation. Medications, such as beta-blockers or calcium channel blockers, are used to slow down the electrical signals in the heart. Radiofrequency ablation is a procedure in which a catheter is inserted into the heart, and high-frequency energy is used to destroy the abnormal electrical pathways in the AV node.
Atrioventricular nodal reentrant tachycardia (AVNRT) is a type of arrhythmia that affects the heart’s electrical system and causes an abnormally rapid heartbeat. It is usually benign and does not cause any long-term damage to the heart, but it can cause uncomfortable symptoms such as dizziness, lightheadedness, palpitations, chest pain, and shortness of breath. AVNRT is usually diagnosed through an electrocardiogram or an echocardiogram, and can be treated with medication or with a procedure known as radiofrequency ablation. Understanding the anatomy and mechanisms of AVNRT is essential in diagnosing and treating this condition.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation